Binimetinib and Kisqali (200 MG Dose)
Determining the interaction of Binimetinib and Kisqali (200 MG Dose) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Ribociclib may increase the blood levels and effects of binimetinib. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with inhibitors of P-glycoprotein (P-gp), uridine diphosphate glucuronosyltransferase (UGT) 1A1 or 2B7, and/or breast cancer resistance protein (BCRP) may increase the plasma levels and risk of adverse effects of binimetinib. The proposed mechanism involves the reduced metabolic clearance of binimetinib through inhibition of P-gp, UGT 1A1, UGT 2B7, and/or BCRP. The clinical significance of this interaction is unknown as no clinically relevant drug interactions have been demonstrated with binimetinib.
MANAGEMENT: Until further information is available, caution is recommended if binimetinib must be used concomitantly with P-gp, UGT 1A1, UGT 2B7, and/or BCRP inhibitors. Binimetinib should be monitored more closely whenever a P-gp, UGT 1A1, UGT 2B7, and/or BCRP inhibitor is added to or withdrawn from therapy, and the binimetinib dosage adjusted as necessary.
- "Product Information. Mektovi (binimetinib)." Array BioPharma Inc., Boulder, CO.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Binimetinib-Kisqali (400 MG Dose)
- Binimetinib-Kisqali (600 MG Dose)
- Binimetinib-Kisqali Femara Co-Pack
- Binimetinib-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Binimetinib-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Binimetinib-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Binora Topical
- Kisqali (200 MG Dose)-Binosto
- Kisqali (200 MG Dose)-Bio Glo
- Kisqali (200 MG Dose)-Bio-Cef
- Kisqali (200 MG Dose)-Bio-D-Mulsion
- Kisqali (200 MG Dose)-Bio-D-Mulsion Forte